158 related articles for article (PubMed ID: 23869492)
1. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
He YM; Feng L; Huo DM; Yang ZH; Liao YH
Nephrology (Carlton); 2013 Sep; 18(9):605-14. PubMed ID: 23869492
[TBL] [Abstract][Full Text] [Related]
2. Losartan and enalapril are comparable in reducing proteinuria in children.
Webb NJ; Shahinfar S; Wells TG; Massaad R; Gleim GW; Santoro EP; Sisk CM; Lam C
Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
[TBL] [Abstract][Full Text] [Related]
3. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Mauer M; Zinman B; Gardiner R; Suissa S; Sinaiko A; Strand T; Drummond K; Donnelly S; Goodyer P; Gubler MC; Klein R
N Engl J Med; 2009 Jul; 361(1):40-51. PubMed ID: 19571282
[TBL] [Abstract][Full Text] [Related]
4. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M; Tylicki L; Rutkowski P; Rutkowski B
Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
Reyes-Marín FA; Calzada C; Ballesteros A; Amato D
Rev Invest Clin; 2012; 64(4):315-21. PubMed ID: 23227581
[TBL] [Abstract][Full Text] [Related]
6. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
Webb NJ; Shahinfar S; Wells TG; Massaad R; Gleim GW; McCrary Sisk C; Lam C
Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
[TBL] [Abstract][Full Text] [Related]
7. [Prescription of renin-angiotensin-aldosterone system blockers in patients with stage 3 chronic kidney disease].
Alvarez M; Ardiles L
Rev Med Chil; 2019 Feb; 147(2):173-180. PubMed ID: 31095165
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
[TBL] [Abstract][Full Text] [Related]
9. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
[TBL] [Abstract][Full Text] [Related]
10. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
11. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
12. Cough induced by losartan with resolution after substitution with enalapril.
Dashti-Khavidaki S; Faghihi T; Ahmadi F; Khalili H
Clin Ther; 2008 Mar; 30(3):548-51. PubMed ID: 18405793
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
14. Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
Juhlin T; Erhardt LR; Ottosson H; Jönsson BA; Höglund P
Eur J Heart Fail; 2007 Feb; 9(2):191-6. PubMed ID: 16859993
[TBL] [Abstract][Full Text] [Related]
15. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
Caletti MG; Balestracci A; Missoni M; Vezzani C
Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713
[TBL] [Abstract][Full Text] [Related]
16. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
Tylicki L; Renke M; Rutkowski P; Rutkowski B; Lysiak-Szydłowska W
Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705
[TBL] [Abstract][Full Text] [Related]
17. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
18. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
[TBL] [Abstract][Full Text] [Related]
19. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
Sakallı H; Baskın E; Bayrakcı US; Moray G; Haberal M
Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease.
Wu PC; Wu CJ; Lin CJ; Pan CF; Chen CY; Huang TM; Wu CH; Lin SL; Chen YM; Chen L; Wu VC; ;
Clin Pharmacol Ther; 2015 Oct; 98(4):442-9. PubMed ID: 26082272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
